Susquehanna International Group
RARE icon

Susquehanna International Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Susquehanna International Group’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.69M Sell
367,100
-264,200
-42% -$5.95M ﹤0.01% 3515
2025
Q4 		$14.5M Buy
631,300
+322,900
+105% +$10.6M ﹤0.01% 2575
2025
Q3 		$9.28M Sell
308,400
-155,200
-33% -$4.65M ﹤0.01% 3131
2025
Q2 		$16.9M Buy
463,600
+280,900
+154% +$10.1M ﹤0.01% 2184
2025
Q1 		$6.62M Sell
182,700
-129,200
-41% -$5.37M ﹤0.01% 3148
2024
Q4 		$13.1M Buy
311,900
+131,200
+73% +$6.51M ﹤0.01% 2315
2024
Q3 		$10M Buy
180,700
+81,700
+83% +$4.16M ﹤0.01% 2608
2024
Q2 		$4.07M Sell
99,000
-36,400
-27% -$1.55M ﹤0.01% 3789
2024
Q1 		$6.32M Sell
135,400
-41,600
-24% -$1.96M ﹤0.01% 3259
2023
Q4 		$8.46M Sell
177,000
-49,800
-22% -$1.93M ﹤0.01% 2876
2023
Q3 		$8.09M Buy
226,800
+69,100
+44% +$2.74M ﹤0.01% 2830
2023
Q2 		$7.27M Buy
157,700
+78,600
+99% +$3.65M ﹤0.01% 2947
2023
Q1 		$3.17M Sell
79,100
-38,800
-33% -$1.66M ﹤0.01% 4213
2022
Q4 		$5.46M Buy
117,900
+26,400
+29% +$1.04M ﹤0.01% 3101
2022
Q3 		$3.79M Buy
91,500
+63,200
+223% +$3.25M ﹤0.01% 3619
2022
Q2 		$1.69M Buy
28,300
+22,400
+380% +$1.38M ﹤0.01% 5269
2022
Q1 		$428K Sell
5,900
-6,100
-51% -$424K ﹤0.01% 9376
2021
Q4 		$1.01M Buy
12,000
+5,200
+76% +$423K ﹤0.01% 7272
2021
Q3 		$613K Sell
6,800
-31,100
-82% -$2.81M ﹤0.01% 8863
2021
Q2 		$3.61M Sell
37,900
-3,000
-7% -$313K ﹤0.01% 4653
2021
Q1 		$4.66M Sell
40,900
-15,000
-27% -$2.04M ﹤0.01% 4035
2020
Q4 		$7.74M Buy
55,900
+49,900
+832% +$5.92M ﹤0.01% 2808
2020
Q3 		$493K Sell
6,000
-43,000
-88% -$3.56M ﹤0.01% 7710
2020
Q2 		$3.83M Sell
49,000
-63,600
-56% -$4.21M ﹤0.01% 3393
2020
Q1 		$5M Sell
112,600
-10,500
-9% -$545K ﹤0.01% 2570
2019
Q4 		$5.26M Buy
123,100
+35,600
+41% +$1.47M ﹤0.01% 2903
2019
Q3 		$3.74M Sell
87,500
-1,500
-2% -$81.5K ﹤0.01% 3145
2019
Q2 		$5.65M Buy
89,000
+22,100
+33% +$1.41M ﹤0.01% 2556
2019
Q1 		$4.64M Buy
66,900
+26,700
+66% +$1.53M ﹤0.01% 2549
2018
Q4 		$1.75M Sell
40,200
-29,300
-42% -$1.6M ﹤0.01% 3720
2018
Q3 		$5.31M Sell
69,500
-79,100
-53% -$6.43M ﹤0.01% 2620
2018
Q2 		$11.4M Sell
148,600
-30,800
-17% -$1.99M ﹤0.01% 1806
2018
Q1 		$9.15M Buy
179,400
+37,700
+27% +$1.9M ﹤0.01% 1866
2017
Q4 		$6.57M Buy
141,700
+17,100
+14% +$838K ﹤0.01% 2229
2017
Q3 		$6.64M Buy
124,600
+70,100
+129% +$4.15M ﹤0.01% 2174
2017
Q2 		$3.38M Sell
54,500
-30,600
-36% -$1.84M ﹤0.01% 2964
2017
Q1 		$5.77M Buy
85,100
+26,900
+46% +$2.05M ﹤0.01% 2205
2016
Q4 		$4.09M Buy
58,200
+4,700
+9% +$333K ﹤0.01% 2752
2016
Q3 		$3.79M Sell
53,500
-35,800
-40% -$2.29M ﹤0.01% 2583
2016
Q2 		$4.37M Buy
89,300
+17,300
+24% +$1.12M ﹤0.01% 2379
2016
Q1 		$4.56M Buy
72,000
+25,800
+56% +$1.69M ﹤0.01% 2426
2015
Q4 		$5.18M Buy
46,200
+24,500
+113% +$2.45M ﹤0.01% 2500
2015
Q3 		$2.09M Sell
21,700
-8,800
-29% -$1.01M ﹤0.01% 4192
2015
Q2 		$3.12M Buy
30,500
+15,000
+97% +$1.16M ﹤0.01% 3773
2015
Q1 		$962K Buy
15,500
+6,500
+72% +$361K ﹤0.01% 5842
2014
Q4 		$395K Sell
9,000
-1,900
-17% -$87.1K ﹤0.01% 7671
2014
Q3 		$617K Buy
10,900
+6,300
+137% +$317K ﹤0.01% 6826
2014
Q2 		$206K Buy
+4,600
New +$189K ﹤0.01% 9010

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Susquehanna International Group's RARE Position: Q1 2026 in Review

Susquehanna International Group increased its Ultragenyx Pharmaceutical (RARE) stake by 245% in Q1 2026, buying an estimated $8.39M and bringing the position to 524,798 shares worth $11M. The position accounts for ﹤0.01% of the portfolio, ranked #2979.

Susquehanna International Group first reported a position in RARE in Q2 2014 and has held it in 39 quarters since. 295 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • Susquehanna International Group held 524,798 shares of Ultragenyx Pharmaceutical worth $11M as of Q1 2026.
  • Susquehanna International Group bought 372,482 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $8.39M.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2979 holding.
  • Susquehanna International Group first reported a position in Ultragenyx Pharmaceutical in Q2 2014 and has held it in 39 quarters since.
  • 295 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.